脑微出血与阿尔茨海默病关系的研究进展

doi:10.3969/j.issn.1673-5765.2021.04.002

摘要/Abstract

摘要：

脑微出血（cerebral microbleeds，CMBs）是直径为2～10 mm的圆形或椭圆形低密度病变，病灶周围无水肿，经T2 *梯度回波或SWI检查可以被发现，是脑小血管病的一种病理改变。随着影像学技术的发展，CMBs在阿尔茨海默病（Alzheimer’s disease，AD）中的检出率不断升高。AD患者CMBs发生率高于健康人群及痴呆症患者，且主要分布在脑叶。CMBs可以通过参与颅内淀粉样变性和神经元变性，与载脂蛋白E基因产生关联及影响血脑屏障等方式在AD疾病进展中发挥作用。

文章导读： 本文介绍了AD患者CMBs的流行病学特点和分布特征，探讨了CMBs与AD之间的关系，这为临床筛查认知障碍高危群体提供依据。

关键词: 脑微出血; 阿尔茨海默病; 认知功能

Abstract:

Cerebral microbleed (CMB) is a circular or elliptical low-density lesion with a diameter of 2-10 mm, with no edema around the lesion, which can be found by T2 * GRE or SWI. CMB is a pathological change of cerebral small vessel disease. With the development of imaging technology, the detection rate of CMB in Alzheimer's disease (AD) is increasing. The incidence of CMBs in AD patients is higher than that in the healthy and dementia patients, and the CMBs in AD patients mainly located in brain lobes. CMBs play a role in the progression of AD by involving intracranial amyloidosis and neuronal degeneration, being associated with APOE gene, and affecting the blood-brain barrier.

Key words: Cerebral microbleed; Alzheimer's disease; Cognitive function

廖艺斐，张慧，邹良玉. 脑微出血与阿尔茨海默病关系的研究进展[J]. 中国卒中杂志, 2021, 16(04): 327-330.

LIAO Yi-Fei, ZHANG Hui,ZOU Liang-Yu. Progress of Relationship between Cerebral Microbleeds and Alzheimer's Disease[J]. Chinese Journal of Stroke, 2021, 16(04): 327-330.

参考文献

[1] BOYANO I，BRAVO N，MIRANDA J，et al.

Brain microbleeds：epidemiology and clinical

implications[J]. Neurologia，2018，33（8）：515-525.

[2] SHAMS S，MARTOLA J，GRANBERG T，et

al. Cerebral microbleeds：different prevalence，

topography，and risk factors depending on dementia

diagnosis—the Karolinska Imaging Dementia

Study[J]. AJNR Am J Neuroradiol，2015，36（4）：

661-666.

[3] SPARACIA G，AGNELLO F，LA TONA G，et

al. Assessment of cerebral microbleeds by

susceptibility-weighted imaging in Alzheimer's

disease patients：a neuroimaging biomarker of the

disease[J]. Neuroradiol J，2017，30（4）：330-335.

[4] WHITWELL J L，KANTARCI K，WEIGAND S

D，et al. Microbleeds in atypical presentations of

Alzheimer's disease：a comparison to dementia of

the Alzheimer's type[J]. J Alzheimers Dis，2015，45

（4）：1109-1117.

[5] RABELO A G，TEIXEIRA C V，MAGALHÃES

T N，et al. Is cerebral microbleed prevalence

relevant as a biomarker in amnestic mild cognitive

impairment and mild Alzheimer's disease?[J].

Neuroradiol J，2017，30（5）：477-485.

[6] GREGOIRE S M，CHAUDHARY U J，BROWN

M M，et al. The Microbleed Anatomical Rating

Scale（MARS）：reliability of a tool to map brain

microbleeds[J]. Neurology，2009，73（21）：1759-

1766.

[7] ZHANG J B，LI M F，ZHANG H X，et al.

Association of serum vascular endothelial growth

factor levels and cerebral microbleeds in patients

with Alzheimer's disease[J]. Eur J Neurol，2016，23

（8）：1337-1342.

[8] HATADA Y，HASHIMOTO M，SHIRAISHI

S，et al. Cerebral microbleeds are associated with

cerebral hypoperfusion in patients with Alzheimer's

disease[J]. J Alzheimers Dis，2019，71（1）：273-280.

[9] GOOS J D，KESTER M I，BARKHOF F，et al.

Patients with Alzheimer disease with multiple

microbleeds：relation with cerebrospinal fluid

biomarkers and cognition[J]. Stroke，2009，40（11）：

3455-3460.

[10] CHIANG G C，CRUZ HERNANDEZ J C，

KANTARCI K，et al. Cerebral microbleeds，CSF

p-tau，and cognitive decline：significance of

anatomic distribution[J]. AJNR Am J Neuroradiol，

2015，36（9）：1635-1641.

[11] BASSELERIE H，BRACOUD L，ZEESTRATEN

E，et al. Incident cerebral microbleeds detected

by susceptibility weight-imaging help to identify

patients with mild cognitive impairment progressing

to alzheimer's disease[J]. J Alzheimers Dis，2017，60

（1）：253-262.

[12] SEPEHRY A A，RAUSCHER A，HSIUNG G

Y，et al. Microbleeds in Alzheimer's disease：a

neuropsychological overview and meta-analysis[J].

Can J Neurol Sci，2016，43（6）：753-759.

[13] HERINGA S M，REIJMER Y D，LEEMANS

A，et al. Multiple microbleeds are related to

cerebral network disruptions in patients with early

Alzheimer's disease[J]. J Alzheimers Dis，2014，38

（1）：211-221.

[14] POLIAKOVA T，LEVIN O，ARABLINSKIY A，

et al. Cerebral microbleeds in early Alzheimer's

disease[J]. J Neurol，2016，263（10）：1961-1968.

[15] LAMBERT J C，IBRAHIM-VERBAAS C

A，HAROLD D，et al. Meta-analysis of 74，046

individuals identifies 11 new susceptibility loci for

Alzheimer's disease[J]. Nat Genet，2013，45（12）：

1452-1458.

[16] FARRER L A，CUPPLES L A，HAINES J L，et al.

Effects of age，sex，and ethnicity on the association

between apolipoprotein E genotype and Alzheimer

disease. A meta-analysis. APOE and Alzheimer

disease meta analysis consortium[J]. JAMA，1997，

278（16）：1349-1356.

[17] KIM Y J，CHO S K，KIM H J，et al. Data-driven

prognostic features of cognitive trajectories in

patients with amnestic mild cognitive impairments[J].

Alzheimers Res Ther，2019，11（1）：10.

[18] JACK C R Jr，WISTE H J，THERNEAU T M，et al.

Associations of amyloid，tau，and neurodegeneration

biomarker profiles with rates of memory decline

among individuals without dementia[J]. JAMA，2019，

321（23）：2316-2325.

[19] DUITS F H，HERNANDEZ-GUILLAMON M，

MONTANER J，et al. Matrix metalloproteinases

in Alzheimer's disease and concurrent cerebral

microbleeds[J]. J Alzheimers Dis，2015，48（3）：

711-720.